LEXICON PHARMACEUTICALS, INC.·4

Feb 29, 4:28 PM ET

Granowitz Craig B 4

4 · LEXICON PHARMACEUTICALS, INC. · Filed Feb 29, 2024

Insider Transaction Report

Form 4
Period: 2024-02-28
Granowitz Craig B
SVP, Chief Medical Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2024-02-28+27,91643,101 total
  • Exercise/Conversion

    Common Stock

    2024-02-28+35,79078,891 total
  • Tax Payment

    Common Stock

    2024-02-28$2.62/sh31,265$81,91447,626 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-02-2827,91627,917 total
    Common Stock (27,916 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2024-02-2835,79071,580 total
    Common Stock (35,790 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
  • [F2]Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
  • [F3]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT